Skip to main content

Advertisement

Table 1 Baseline clinical characteristics

From: Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome

Variables All patients Low MAGE High MAGE p-value
(n = 417) (n = 268) (n = 149)
Age, years 66 (56–74) 66 (56–74) 68 (58–75) 0.275
Male, n (%) 348 (83) 219 (82) 129 (85) 0.201
Body mass index, kg/m2 26.8 (22.1–29.5) 24.5 (22.4–27.3) 23.9 (21.8–26.1) 0.010
STE-ACS, n (%) 292 (70) 191 (71) 101 (68) 0.457
Killip class > 1, n (%) 74 (18) 40 (15) 34 (23) 0.042
Infarct-related artery, n (%)
 Left anterior descending coronary artery, n (%) 229 (55) 150 (56) 79 (53) 0.562
 Left circumflex coronary artery, n (%) 45 (11) 29 (11) 16 (11) 0.979
 Right coronary artery, n (%) 143 (34) 89 (33) 54 (36) 0.532
Multivessel disease, n (%) 176 (42) 99 (37) 77 (52) 0.004
GRACE score > 140, n (%) 212 (51) 125 (47) 87 (58) 0.022
Hypertension, n (%) 255 (61) 155 (58) 100 (67) 0.063
Hypercholesteremia, n (%) 160 (38) 109 (41) 51 (34) 0.195
Systolic blood pressure on admission, mmHg 150 (125–170) 149 (125–167) 153 (124–177) 0.806
Heart rate on admission, bpm 76 (64–88) 76 (64–88) 76 (65–90) 0.575
Laboratory data
 Cre on admission, mg/dl 0.84 (0.72–1.00) 0.84 (0.73–0.98) 0.83 (0.71–1.02) 0.720
 eGFR on admission, % 67.9 (56.3–81.1) 67.3 (55.9–80.0) 70.4 (56.3–83.1) 0.091
 Peak level of CPK, IU/l 1129 (250–2864) 1130 (243–2870) 1129 (265–2838) 0.696
 BNP during stable phase, pg/ml 89.2 (35.5–192.7) 80.4 (35.4–171.4) 101.3 (37.7–209.1) 0.007
 hs-CRP during stable phase > 0.1355 mg/dl, n (%) 185 (44) 115 (43) 70 (47) 0.393
Lipid profile on admission
 LDL cholesterol, mg/dl 128 (105–152) 131 (108–155) 124 (102–148) 0.114
 HDL cholesterol, mg/dl 44 (37–52) 43 (37–51) 45 (37–52.5) 0.131
 Triglycerides, mg/dl 118 (75–185) 124 (78–197) 113 (70–162) 0.125
Medication on discharge, n (%)
 ACE-I or ARB 334 (80) 210 (78) 124 (83) 0.233
 β-blocker 275 (66) 175 (65) 100 (67) 0.708
 Statin 400 (96) 258 (96) 142 (95) 0.632
  1. STE-ACS ST-segment elevation acute coronary syndrome, GRACE score grobal registry of coronary event, Cre creatinine, eGFR estimated glomerular filtration rate, CPK creatine phosphokinase, BNP B-type natriuretic peptide, hs-CRP high sensitivity C-reactive protein, LDLC low-density lipoprotein cholesterol, HDLC high-density lipoprotein cholesterol, ACE-I angiotensin-converting enzyme-inhibitors, ARB angiotensin II receptor blockers